Summary
Researchers are investigating the efficacy of inhalation of Dugdhika (Euphorbia prostrata) compared to salbutamol in the treatment of Tamaka Shwasa, or bronchial asthma. The research protocol, led by Bhavesh Dangore and Sadhana Misar Wajpeyi, aims to evaluate how the plant may act in reducing asthmatic symptoms. Inhalation of Dugdhika is a traditional approach that may offer additional benefits, considering its anti-inflammatory and bronchodilatory properties. The study aims to provide concrete data on comparative efficacy, which may enrich clinical practice by integrating Ayurvedic knowledge with modern evidence. The focus on inhalation of a traditional herb may open new possibilities for asthma management, especially in contexts where conventional treatments are insufficient or present unwanted side effects.
Key points
- Dugdhika (Euphorbia prostrata) may have bronchodilatory and anti-inflammatory properties.
- The study directly compares the efficacy of Dugdhika inhalation with salbutamol, a common bronchodilator.
- The research is a protocol, so results are not yet available, but the methodology is promising.
✦ For you
If you suffer from asthma, consider observing how different treatments affect your breathing. Pay attention to symptoms and how they respond to changes in your routine, such as exercise practice or dietary changes. It is important to keep a symptom diary and discuss any changes with a qualified healthcare professional.
For practitionersExpand
This research protocol may be a starting point to explore the inclusion of Dugdhika (Euphorbia prostrata) in asthma treatments. Evaluate patient response to salbutamol and consider Dugdhika inhalation as an alternative or complement, especially in cases where conventional treatments are not effective.